Vaccinex Inc - ESG Rating & Company Profile powered by AI
This assessment of Vaccinex Inc is prepared by All Street Sevva using proprietary AI. Check the end of the webpage for potential risks for Vaccinex Inc based on sector, geography and marketcap. This dashboard includes a questions and answers table for Vaccinex Inc.
Vaccinex Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 2.0, social score of 2.7 and governance score of 2.3.
2.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2019 | Woojung Bio Inc | 2.4 | Medium |
| 2019 | Vista Pharmaceuticals Ltd | 2.4 | Medium |
| 2059 | Vaccinex Inc | 2.3 | Medium |
| 2059 | AbClon Inc | 2.3 | Medium |
| 2059 | Adhera Therapeutics Inc | 2.3 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Vaccinex Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Vaccinex Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Vaccinex Inc report the average age of the workforce?
Sign up for free to unlockDoes Vaccinex Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Vaccinex Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Vaccinex Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Vaccinex Inc offer flexible work?
Sign up for free to unlockDoes Vaccinex Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Vaccinex Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Vaccinex Inc conduct supply chain audits?
Sign up for free to unlockDoes Vaccinex Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Vaccinex Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Vaccinex Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Vaccinex Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Vaccinex Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Vaccinex Inc disclose water use targets?
Sign up for free to unlockDoes Vaccinex Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Vaccinex Inc have a product recall in the last two years?
Sign up for free to unlockDoes Vaccinex Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Vaccinex Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Vaccinex Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Vaccinex Inc disclose parental leave metrics?
Sign up for free to unlockDoes Vaccinex Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Vaccinex Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Vaccinex Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Vaccinex Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Vaccinex Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Vaccinex Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Vaccinex Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Vaccinex Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Vaccinex Inc disclose its waste policy?
Sign up for free to unlockDoes Vaccinex Inc report according to TCFD requirements?
Sign up for free to unlockDoes Vaccinex Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Vaccinex Inc disclose energy use targets?
Sign up for free to unlockDoes Vaccinex Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Vaccinex Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Vaccinex Inc
These potential risks are based on the size, segment and geographies of the company.
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed a proprietary drug discovery platform, ActivMAb that it is leveraging through strategic collaborations, by exploiting its unique capability to select antibodies against multi-pass membrane receptors. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.